🇺🇸 FDA
Patent

US 10286044

Soluble hyaluronidase glycoprotein (sHASEGP), process for preparing the same, uses and pharmaceutical compositions comprising thereof

granted A61KA61K2039/505A61K38/00

Quick answer

US patent 10286044 (Soluble hyaluronidase glycoprotein (sHASEGP), process for preparing the same, uses and pharmaceutical compositions comprising thereof) held by HALOZYME, INC. expires Mon May 09 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
HALOZYME, INC.
Grant date
Tue May 14 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 09 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
22
CPC classes
A61K, A61K2039/505, A61K38/00, A61K38/47, A61K39/395